急性格林巴利综合征的诊疗进展  

Diagnosis and treatment progress of Guillain-Barré syndrome

作　　者：王悦[1] WANG Yue(General Hospital of Tianjin Medical University,Tianjin,300052)

机构地区：[1]天津医科大学总医院,天津300052

出　　处：《实用临床医药杂志》2020年第3期124-128,共5页Journal of Clinical Medicine in Practice

摘　　要：急性格林巴利综合征(GBS)是一种常见的神经系统疾病,可引起急性迟缓性瘫痪。最新研究发现,GBS包含一组自身免疫相关的周围神经疾病,由不同自身抗体介导产生了不同的临床表型及病生理改变。临床主要以静脉滴注丙种球蛋白及血浆置换为最佳治疗方案。随着对GBS病生理机制研究的不断深入,未来将会有更多的诊治方案服务于临床。Guillain-Barrésyndrome(GBS)is a most common nervous system disease that may cause acute delayed paralysis.The findings of latest researches showed that GBS includes a group of autoimmunity related peripheral nervous disease presenting varied clinical phenotype and pathophysiological changes.The clinical top priority to choose the treatments were intravenous infusion of gamma globulin and plasma exchange.With the rapidly deepening of pathological mechanisms of GBS,new treatment approaches will appearto serve in clinical care.

关 键 词：急性格林巴利综合征 免疫机制 诊疗进展 自身抗体 

分 类 号：R767.6[医药卫生—耳鼻咽喉科]